Application of 18F-FDG PET/CT-guided percutaneous biopsy to differential diagnosis of peritoneal thickening diseases
10.3969/j.issn.1674-8115.2020.05.013
- VernacularTitle: 18F-FDG PET/CT 引导下穿刺活检在腹膜增厚性疾病良恶性鉴别中的应用
- Author:
Hai-Yan WANG
1
Author Information
1. Department of Nuclear Medicine, Shanghai East Hospital, Tongji University
- Publication Type:Journal Article
- Keywords:
18F-flurodeoxyglucose (18F-FDG);
Percutaneous biopsy;
Peritoneum;
Positron emission tomography/computed tomography (PET/CT)
- From:
Journal of Shanghai Jiaotong University(Medical Science)
2020;40(5):646-650
- CountryChina
- Language:Chinese
-
Abstract:
Objective • To investigate the clinical value of 18F-flurodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/ CT)-guided percutaneous biopsy in peritoneal thickening of unknown origin. Methods • Ten cases of peritoneal thicken of unknown origin including 4 males and 6 females were analyzed. After 18F-FDG PET/CT examination, the peritoneal thickening regions with high 18F-FDG uptake were selected for the target areas. Percutaneous biopsy was operated under the guidance of the same PET/CT machine. Results • All lesions were successfully obtained by one-time puncture without serious complications, and histopathological diagnosis revealed that 7 cases were malignant, including 4 cases of peritoneal metastasis and 3 cases of lymphoma. The remaining cases were 1 case of pseudomyxoma, 1 case of tuberculosis and 1 case of inflammatory lesions. The accuracy of biopsy was 100%. Conclusion • 18F-FDG PET/CT-guided peritoneal percutaneous biopsy is a safe and effective method, and may play an important role in differential diagnosis and treatment management.
